An uncommon presentation of the co-existence of morphea and vitiligo in a patient with chronic hepatitis B virus infection: Is there a possible association with autoimmunity?

American Journal of Clinical Dermatology

Volumn 10, Issue 5, 2009, Pages 336-338

  Soylu, Seçil ^a,c   Gül, Ülker ^a   Gönül, Müzeyyen ^a   Kiliç, Arzu ^a   Çakmak, Seray Külcü ^a   Demiriz, Murat ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Military Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; LAMIVUDINE; PSORALEN;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD CELL COUNT; BLOOD CHEMISTRY; CASE REPORT; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; MALE; MORPHEA; PRIORITY JOURNAL; SCLERODERMA; SKIN EXAMINATION; THYROID FUNCTION TEST; ULTRAVIOLET A RADIATION; URINALYSIS; VITILIGO;

ADULT; AUTOIMMUNITY; HEPATITIS B, CHRONIC; HUMANS; IMMUNE SYSTEM; MALE; SCLERODERMA, LOCALIZED; VITILIGO;

EID: 68949163660     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11310800-000000000-00000     Document Type: Article

References (17)

1. Yu BD, Eisen AZ. Scleroderma. In: Freedberg IM, Eisen AZ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. New York (PA): McGraw-Hill Publishers, 2003: 1709-1718
2. Takehara K, Sato S. Localized scleroderma is an autoimuune disorder. Rheumatology 2005; 44: 274-279
3. Arican O, Sasmaz S, Kokoglu OF. Role of hepatitis B and C viruses in the etiopathogenesis of vitiligo. J Dermatol 2004; 31: 506-507
4. Yamamoto T, Nishioka K. Vitiligo vulgaris associated with hepatitis C virus. J Dermatol 2000; 27: 416-417
5. Grimes PE, Seval JS, Vojdani A. Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo. J Am Acad Dermatol 1996; 35:21-26
6. Iverson MV. Hypothesis: vitiligo virus [letter]. Pigment Cell Res 2000; 13:281-282
7. Dervis E, Acbay O, Barut G, et al. Association of vitiligo, morphea, and Hashimoto's thyroiditis. Int J Dermatol 2004; 43: 236-237
8. Brenner W, Diem E, Gschnait F. Coincidence of vitiligo, alopecia areata, onychodystrophy, localized scleroderma and lichen planus. Dermatologica 1979; 159: 356-360
9. Finkelstein E, Amichai B, Metzker A. Coexistence of vitiligo and morphea: a case report and review of the literature. J Dermatol 1995; 22: 351-353
10. Saihan EM, Peachey RD. Vitiligo and morphoea. Clin Exp Dermatol 1979; 4: 103-106
11. Bonifati C, Impara G, Morrone A, et al. Simultaneous occurrence of linear scleroderma and homolateral segmental vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 63-65
12. Cui J, Arita Y, Bystryn JC. Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol 1993; 100: 812-815
13. Mandry RC, Ortiz LJ. Organ-specific autoantibodies in vitiligo patients and their relatives. Int J Dermatol 1996; 35: 18-21
14. Naughton GK, Eisinger M, Bystryn JC. Detection of antiboides to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol 1983; 81: 540-542
15. Akcan Y, Kavak A, Sertbas Y, et al. The low seropositivity of hepatitis B virus in vitiligo patients. J Eur Acad Dermatol Venereol 2006; 20: 110-111
16. Adiloǧlu AK, Basak PY, Baysal V. Clinical evaluation of vitiligo and its relationship with viral hepatitis [letter]. J Eur Acad Dermatol Venereol 2003; 17: 365-366
17. Harrington CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with localized morphoea. Br J Dermatol 1989; 120: 645-648